Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure
Hansoh BioMedical R&D Company
Hansoh BioMedical R&D Company
Children's Oncology Group
UNICANCER
Children's Cancer Hospital Egypt 57357
Children's Oncology Group
Karolinska University Hospital
Children's Oncology Group
The Hospital for Sick Children
Barbara Ann Karmanos Cancer Institute
University of South Florida
INSYS Therapeutics Inc
National Institutes of Health Clinical Center (CC)
Gustave Roussy, Cancer Campus, Grand Paris